Etoziryl 100 MG Injection 5 ML

Etoziryl 100 MG Injection 5 ML may interact with the following medicines:

• CYP3A4 inhibitors (ketoconazole and clarithromycin): These medicines slow down the metabolism of Etoposide in the liver, leading to higher concentrations of the medicine in the bloodstream. This may increase the risk of side effects like low blood cell counts, nausea, and liver toxicity.
• CYP3A4 inducers (rifampin, phenytoin): These medicines enhance the metabolism of Etoposide, reducing its levels in the bloodstream and potentially compromising its anti-cancer effects.
• Anticoagulants (warfarin): Etoposide can alter the liver enzymes responsible for metabolising warfarin, increasing the risk of bleeding complications. Close monitoring of INR (International Normalized Ratio) is required when these medicines are used together.

Etoziryl 100 MG Injection 5 ML can interact with conditions/diseases, including

• Myelosuppression: This medicine can further suppress bone marrow function, leading to decreased blood cell counts (white cells, red cells, and platelets). Close monitoring of blood counts is essential to prevent severe infections or bleeding.
• Liver diseases: Since this medicine is metabolized in the liver, impaired liver function can reduce its clearance, leading to drug accumulation and increased toxicity. Dose adjustments and liver function monitoring are necessary in such patients.
• Kidney disease: This injection may worsen the condition further.

Your doctor will decide on the recommended dose of Etoziryl 100 MG Injection 5 ML for your condition.

Overdose of Etoziryl 100 MG Injection 5 ML is unlikely as a healthcare professional administers it. 

If you miss a scheduled dose of Etoziryl 100 MG Injection 5 ML, take it as soon as you remember. However, avoid repeating the dose. Consult your doctor for more advice.